Atectura Breezhaler Evrópusambandið - íslenska - EMA (European Medicines Agency)

atectura breezhaler

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Bemrist Breezhaler Evrópusambandið - íslenska - EMA (European Medicines Agency)

bemrist breezhaler

novartis europharm limited  - indacaterol, mometasone furoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Kalmente (Nionase) Nefúði, dreifa 50 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

kalmente (nionase) nefúði, dreifa 50 míkróg/skammt

zentiva k.s.* - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt

Enerzair Breezhaler Evrópusambandið - íslenska - EMA (European Medicines Agency)

enerzair breezhaler

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - lyf til veikindi öndunarvegi sjúkdómum, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Zimbus Breezhaler Evrópusambandið - íslenska - EMA (European Medicines Agency)

zimbus breezhaler

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - maintenance treatment of asthma in adults whose disease is not adequately controlled.

Mometason Apofri Nefúði, dreifa 50 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

mometason apofri nefúði, dreifa 50 míkróg/skammt

evolan pharma ab - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt

Nasonex Nefúði, dreifa 50 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

nasonex nefúði, dreifa 50 míkróg/skammt

n.v. organon* - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt

Elocon Krem 0,1 % Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elocon krem 0,1 %

n.v. organon* - mometasonum fúróat - krem - 0,1 %

Elocon Smyrsli 0,1 % Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elocon smyrsli 0,1 %

n.v. organon* - mometasonum fúróat - smyrsli - 0,1 %

Elocon Húðlausn 0,1 % Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elocon húðlausn 0,1 %

n.v. organon* - mometasonum fúróat - húðlausn - 0,1 %